摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-Methylmercapto-chinazolin | 13182-59-7

中文名称
——
中文别名
——
英文名称
4-Methylmercapto-chinazolin
英文别名
4-Methylthio-chinazolin;4-(methylthio)quinazoline;4-methylsulfanylquinazoline
4-Methylmercapto-chinazolin化学式
CAS
13182-59-7
化学式
C9H8N2S
mdl
MFCD08002614
分子量
176.242
InChiKey
COABNVNLVJLMAS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.111
  • 拓扑面积:
    51.1
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Asano; Asai, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1958, vol. 78, p. 450,454
    摘要:
    DOI:
  • 作为产物:
    描述:
    4-羟基喹唑啉劳森试剂吡啶sodium hydroxide 作用下, 以 甲醇 为溶剂, 反应 0.66h, 生成 4-Methylmercapto-chinazolin
    参考文献:
    名称:
    Novel series of 8H-quinazolino[4,3-b]quinazolin-8-ones via two Niementowski condensations
    摘要:
    Efficient microwave-assisted multi-step synthesis of 8H-quinazolino[4,3-b]quinazolin-8-one was investigated. The synthesis involved two Niementowski condensations from anthranilic acids. Homogeneous or heterogeneous conditions were studied with the aim to develop convenient syntheses of the desired compounds. (C) 2003 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(03)00053-x
点击查看最新优质反应信息

文献信息

  • [EN] C20-C21 SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS<br/>[FR] AGONISTES DU RÉCEPTEUR DE GLUCOCORTICOÏDE SUBSTITUÉS EN C20-C21
    申请人:SCHERING CORP
    公开号:WO2009085879A2
    公开(公告)日:2009-07-09
    The present invention provides compounds of Formula (I), and pharmaceutically acceptable salts, solvates, esters, prodrugs, tautomers, or isomers of said compounds), having general structure (I); wherein L, R1, R2, R3, R4, R5, and R6 are selected independently of each other and as defined herein. The present invention also provides compounds (and salts, solvates, esters, prodrugs, tautomers, and isomers) of Formulas II, III, IV, V, and Vl, as defined herein. Also provided are pharmaceutical compositions, methods of preparing, and methods of using such compounds in the treatment and prophylaxis of a wide range of immune, autoimmune, and inflammatory diseases and conditions.
    本发明提供了具有一般结构(I)的化合物,以及该化合物的药用盐、溶剂合物、酯、前药、互变体或异构体(包括L、R1、R2、R3、R4、R5和R6在内独立选择的定义)。本发明还提供了根据本文所定义的化合物(和盐、溶剂合物、酯、前药、互变体和异构体)的II、III、IV、V和VI式化合物。还提供了药物组合物、制备方法以及利用这些化合物在治疗和预防各种免疫、自身免疫和炎症性疾病和症状中的方法。
  • The efficient one-step chlorination of methylsulfanyl group on pyrimidine ring system with sulfuryl chloride
    作者:Young Jin Ham、Duck-Hyung Lee、Hwan Geun Choi、Jung-Mi Hah、Taebo Sim
    DOI:10.1016/j.tetlet.2010.06.056
    日期:2010.9
    A facile one-step transformation of methylsulfanyl and arylsulfanyl groups on pyrimidine ring system into the corresponding chloride group was achieved using sulfuryl chloride in acetonitrile/dichloromethane.
    使用乙腈/二氯甲烷中的硫酰氯,可轻松实现嘧啶环系统上甲基硫烷基和芳基硫烷基的一步式转化为相应的氯基。
  • BF <sub>3</sub> ·SMe <sub>2</sub> for Thiomethylation, Nitro Reduction and Tandem Reduction/SMe Insertion of Nitrogen Heterocycles
    作者:Marcus Söderström、Edouard Zamaratski、Luke R. Odell
    DOI:10.1002/ejoc.201900503
    日期:2019.9
    Herein, a general, solvent-free and straightforward thiomethylation of electron deficient heterocycles using BF3⦁SMe2 as a dual thiomethyl source and Lewis acidic activator is presented. A range of ...
    在此,提出了使用 BF3⦁SMe2 作为双硫甲基源和路易斯酸性活化剂对缺电子杂环进行一般的、无溶剂和直接的硫甲基化。一系列...
  • 3-substituted-aminomethyl cephalosporin derivatives
    申请人:ICI Pharma
    公开号:US04678781A1
    公开(公告)日:1987-07-07
    A cephalosporin derivative of the formula I: ##STR1## in which X is S, O, CH.sub.2 or SO, R1 is (optionally-substituted)imidazol-2-yl or one of the C-7 acyl groups known in the cephalosporin art, R2 is hydrogen or methoxy, R3 is carboxy or a biodegradable ester thereof and --R4 is of the formula XII, XIII or XIV: ##STR2## in which R32-R40 inclusive are as defined in the specification; and the salts thereof. Pharmaceutical compositions, methods of manufacture and intermediates are also described.
    公式I的头孢菌素衍生物:##STR1##其中X是S、O、CH.sub.2或SO,R1是(可选取代)咪唑-2-基或头孢菌素领域已知的C-7酰基之一,R2是氢或甲氧基,R3是羧基或其可生物降解酯,--R4是公式XII、XIII或XIV:##STR2##其中R32-R40包括如规范中定义的;及其盐。还描述了制药组合物、制造方法和中间体。
  • A novel general method for preparation of neutral monomethine cyanine dyes
    作者:Todor Deligeorgiev、Stefka Kaloyanova、Aleksey Vasilev
    DOI:10.1016/j.dyepig.2010.10.012
    日期:2011.8
    Two novel general experimental procedures for preparation of neutral monomethine cyanine dyes without using a basic agent have been developed. The procedures allow synthesis of cyanine dyes by reaction of substituted methylthio aromatic heterocycles with different quaternized nitrogen containing heterocycles by simple melting or by their reaction in acetic anhydride for short reaction times. The proposed
    已经开发出两种新颖的不使用碱性试剂制备中性单次甲基花青染料的常规实验程序。该程序允许通过简单的熔融或通过它们在乙酸酐中的短反应时间的反应,使取代的甲硫基芳香族杂环与不同的季铵化的含氮杂环反应来合成花青染料。所提出的方法用途广泛,因为可以使用多种不同的起始原料。
查看更多